StockData
Alnylam Pharmaceuticals, Inc. logo

Alnylam Pharmaceuticals, Inc. (ALNY) stock

ALNYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3047% below fair value
$147.82−1.58 (-1.06%)

Close on Nov 19, 2026Market cap $19.80BP/E 7.7Yield –

Alnylam Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Alnylam Pharmaceuticals's price to book ratio was 15.8× on Nov 11, 2026, against 102.5× a year earlier. Over the last 5 years it ranged from 5.1× to 475.5×, with a median of 24.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202615.8×−74.5
2025Dec 31, 202590.3×−52.1
2022Oct 31, 2022142.4×+115.6
2021Dec 31, 202126.8×+14.4
2020Dec 31, 202012.4×+4.4
2019Dec 31, 20198.0×+3.0
2018Dec 31, 20185.0×−6.1
2017Dec 29, 201711.1×+7.9
2016Dec 30, 20163.2×−2.9
2015Dec 31, 20156.0×−2.2
2014Dec 31, 20148.2×−5.4
2013Dec 31, 201313.7×+8.3
2012Dec 31, 20125.4×+2.7
2011Dec 30, 20112.7×+0.1
2010Dec 31, 20102.6×–

More Alnylam Pharmaceuticals figures

See a number that looks wrong?